334 related articles for article (PubMed ID: 21737894)
1. Updates on treatment of gemcitabine-refractory pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Makrilia N; Syrigos KN; Saif MW
JOP; 2011 Jul; 12(4):351-4. PubMed ID: 21737894
[TBL] [Abstract][Full Text] [Related]
2. Second line therapy for advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Brus C; Saif MW
JOP; 2010 Jul; 11(4):321-3. PubMed ID: 20601802
[TBL] [Abstract][Full Text] [Related]
3. Updates on first-line treatment of metastatic pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Strimpakos AS; Syrigos KN; Saif MW
JOP; 2011 Jul; 12(4):339-42. PubMed ID: 21737891
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics and other molecular targets in the management of pancreatic adenocarcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Merika E; Syrigos KN; Saif MW
JOP; 2010 Jul; 11(4):328-30. PubMed ID: 20601804
[TBL] [Abstract][Full Text] [Related]
5. First-line treatment of metastatic pancreatic adenocarcinoma: can we do better? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Merl MY; Abdelghany O; Li J; Saif MW
JOP; 2010 Jul; 11(4):317-20. PubMed ID: 20601801
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Therapy of Pancreatic Cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Sharma C; Horowitz D; Chabot J; Saif MW
JOP; 2011 Jul; 12(4):343-6. PubMed ID: 21737892
[TBL] [Abstract][Full Text] [Related]
7. Updates in locally advanced pancreatic cancer. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Chang BW; Siccion E; Saif MW
JOP; 2010 Jul; 11(4):313-6. PubMed ID: 20601800
[TBL] [Abstract][Full Text] [Related]
8. Novel agents for the treatment of pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Cheng H; Merika E; Syrigos KN; Saif MW
JOP; 2011 Jul; 12(4):334-8. PubMed ID: 21737890
[TBL] [Abstract][Full Text] [Related]
9. Palliative care of pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Saif MW
JOP; 2011 Jul; 12(4):355-7. PubMed ID: 21737895
[TBL] [Abstract][Full Text] [Related]
10. Novel agents for the treatment of pancreatic adenocarcinoma: any light at the end of the tunnel? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Dimou AT; Syrigos KN; Saif MW
JOP; 2010 Jul; 11(4):324-7. PubMed ID: 20601803
[TBL] [Abstract][Full Text] [Related]
11. Locally advanced pancreatic adenocarcinoma: are we making progress?. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Li J; Ng J; Allendorf J; Saif MW
JOP; 2011 Jul; 12(4):347-50. PubMed ID: 21737893
[TBL] [Abstract][Full Text] [Related]
12. Treatment for refractory pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Makrilia N; Syrigos KN; Saif MW
JOP; 2011 Mar; 12(2):110-3. PubMed ID: 21386632
[TBL] [Abstract][Full Text] [Related]
13. New developments in the treatment of pancreatic cancer. Highlights from the "44th ASCO Annual Meeting". Chicago, IL, USA. May 30 - June 3, 2008.
Saif MW
JOP; 2008 Jul; 9(4):391-7. PubMed ID: 18648128
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer: is this bleak landscape finally changing? Highlights from the '43rd ASCO Annual Meeting'. Chicago, IL, USA. June 1-5, 2007.
Saif MW
JOP; 2007 Jul; 8(4):365-73. PubMed ID: 17625289
[TBL] [Abstract][Full Text] [Related]
15. Updates in pancreatic neuroendocrine carcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Alsamarai S; Libutti SK; Saif MW
JOP; 2010 Jul; 11(4):336-40. PubMed ID: 20601807
[TBL] [Abstract][Full Text] [Related]
16. Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Li J; Merl MY; Chabot J; Saif MW
JOP; 2010 Jul; 11(4):310-2. PubMed ID: 20601799
[TBL] [Abstract][Full Text] [Related]
17. Diabetes and pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Hsu C; Saif MW
JOP; 2011 Jul; 12(4):330-3. PubMed ID: 21737889
[TBL] [Abstract][Full Text] [Related]
18. What options are available for refractory pancreatic cancer?
Choi M; Kim R; Saif MW
JOP; 2012 Mar; 13(2):163-5. PubMed ID: 22406591
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers and pharmacogenetics in pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Xu X; Strimpakos AS; Saif MW
JOP; 2011 Jul; 12(4):325-9. PubMed ID: 21737888
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer: highlights from the 42nd annual meeting of the American Society of Clinical Oncology, 2006.
Saif MW
JOP; 2006 Jul; 7(4):337-48. PubMed ID: 16832131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]